Altamira Therapeutics Completes Final Patient Enrollment in

Altamira Therapeutics Completes Final Patient Enrollment in Phase 2 'TRAVERS' Clinical Trial of AM-125 for the Treatment of Acute Vertigo

Altamira Therapeutics Completes Final Patient Enrollment in Phase 2 'TRAVERS' Clinical Trial of AM-125 for the Treatment of Acute Vertigo
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Bermuda , Switzerland , Thomas Meyer , Stephen Kilmer , Securities Exchange Commission , Altamira Therapeutics Ltd , Data From The National Health , Securities Exchange , Nutrition Examination , Nasdaq , Altamira Therapeutics , Altamira Therapeutic , Tandem Romberg , Vestibular Function , National Health , Nutrition Examination Survey , March Intern , Securities Act , Securities Exchange Act , Risk Factor , Altamira Therapeutic Annual Report , United States Wire Group ,